Full 1
Are our patents valuable?
Where should my R&D be best spent?
How do I manage and prioritize new inventions?
Full 1
Full 1
Where should my R&D be best spent?
How do I manage and prioritize new inventions?
What is everyone in my tech area doing globally?
Full 1

PatentVest is the first Venture Commercialization Intelligence Platform to assist technologists, advisors, venture capitalists, and established companies to optimize technology commercialization

Rational Design Process For New Companies

“Innovation in a box” – our process transforms innovation/IP from a complex legal process into a manageable/measurable business process.

Define icon


Clearly understand what our companies have developed and their vision for their technology to define a space for analysis

Analyze icon


Deeply understand all of the players in the space and how they relate to our companies technology, IP, and new inventions

Report icon


Gain a clear understanding of what our companies competitive advantages will be and articulate a theory of opportunity

Conceive icon


Develop a business, IP, innovation, and R&D strategy that enable our companies to create a new technology category and become the leader of that category

Innovate icon


Re-evaluate continuously, which keeps our company a category leader or enables them to pivot to a new strategy based on changing circumstances

Recent Successes

Companies we have taken through this process, that initially began as abstract ideas

PatentVest client - provention bio - logo
Provention Bio, Inc. (Nasdaq: PRVB) is a clinical-stage biopharmaceutical company leveraging a transformational drug development strategy focused on the prevention or interception of immune-mediated disease.
PatentVest client - provention bio - logo
Cue Biopharma (Nasdaq: CUE), is a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases.
PatentVest client - provention bio - logo
Pulse Biosciences, Inc. (Nasdaq: PLSE) is a clinical-stage medical device company using a platform technology called Nano-Pulse stimulating (NPS).

The Difference

Traditional patent data providers just provide data… we provide strategic guidance, by turning data into answers.

A “paint by numbers” approach. We take the  mystery out of designing a path for technology companies.

Our Reports and Innovation Management solutions answer basic questions and guide basic activities that enables our clients to execute a business, IP, and R&D strategy that is unified & rational.

Should I file a patent?

The average cost to file a patent in the US and WIPO is $56K. Filing globally can range from $200K, upwards to $2M+. For clients with new inventions or provisional patents, we enable you to determine if you should file a patent, and the probability it will be granted.

Are my patents valuable?

Most companies are unaware that their patents lose value during the prosecution process. We enable our clients to strategically monitor and manage their patents and their competitors’ patents in prosecution to develop defensible IP portfolios.

Who are my direct competitors?

Top innovators clearly understand what their company’s sustainable competitive advantage will be and why their technology is unique and valuable. We enable our clients to deeply understand all of the players in the space and how they relate to your companies technology, IP, and new inventions.

Ready to get started?
Take our questionnaire.